ARSB and cystic fibrosis: In addition, decline in ARSB activity led to increased expression of GPNMB (glycoprotein transmembrane nonmetastatic melanoma protein B) in hepatic tissue of ARSB-null mice and to increased levels in plasma and in circulating leukocytes from CF patients and cultured CF bronchial epithelial cells [83].